Paul Greaney, Head of IT
Vernalis Plc is a commercial stage pharmaceutical company with three marketed products, four additional products under development and a broad pipeline of research and development programs.
Given the highly sensitive nature of the R&D performed, securing their email environment from human error is a key priority for the company.
The company had heard of incidents in the past where project related information had been sent to the wrong person and wanted to proactively address this step.
The management team is acutely aware of the potential risks from misdirected emails, and had spent some time looking at various vendors before choosing to work with Tessian because of the way in which the machine learning approach solves the problem.
Tessian was rolled out to 125 users across three Vernalis sites, including the UK and US. Vernalis now use Guardian and Constructor to detect and prevent email threats in the form of misdirected emails and to implement their own custom compliance policy rules.
Tessian’s machine intelligent platform has better equipped Vernalis to protect their firm from human error-related incidents over email.